Hybelius, Jonna
Gustavsson, Anton
af Winklerfelt Hammarberg, Sandra
Toth-Pal, Eva
Johansson, Robert
Ljótsson, Brjánn
Axelsson, Erland https://orcid.org/0000-0003-2562-2925
Funding for this research was provided by:
Karolinska Institute
Article History
Received: 24 November 2021
Accepted: 24 June 2022
First Online: 19 July 2022
Declarations
:
: This trial was approved by the Swedish ethical review authority (2020-01740) and all participants provided informed consent to participate.
: Not applicable.
: EA and BL are co-authors of a self-help book based on exposure for severe health anxiety, available in the public marketplace. BL is also a shareholder of DahliaQomit AB, a company specialising in online psychiatric symptom assessment, and Hedman-Lagerlöf och Ljótsson psykologi AB, a company that licenses exposure-based treatment for irritable bowel syndrome. The other authors declare no competing interests.